Public Release: 

MDA associated with the prevention of a resurgence of malaria in Greece


Greece was declared malaria free in 1974, however, in 2011 a resurgence of P. vivax malaria was seen in Southern Greece in connection with the presence of agricultural workers from malaria-endemic regions in malaria receptive areas. Standard control measures were implemented for one year (i.e. Active case detection, intensifies vector control), after which a program of mass drug administration (MDA) was implemented to provide the entire local immigrant population with a curative course of antimalarial drugs. No malaria cases were reported for the years 2013-2014, when the MDA was on-going.

Since 1974 with only a small and sporadic number of malaria cases have been reported in Greece. However in 2011, 21 P. vivax cases from arriving immigrants were reported in the Southern agricultural area of Evrotas, along with 36 local cases. An integrated control program was immediately implemented, with house visits established to screen immigrants from endemic countries. Screening included a rapid diagnostic test for those reporting compatible symptoms along with blood sampling for smear and molecular testing for malaria. Directly Observed treatment was provided for all who tested positive. A vector control program was also implemented, with indoor residual spraying and long-lasting insecticide nets provided in areas close to mosquito breeding sites.

Despite these interventions 20 more introduced cases were reported in 2012 and, due to fears that the malaria parasite may be re-establishing in the area, a program of mass drug administration of one course of chloroquine and primaquine, which are the first line recommended antimalarials for P. vivax. Adverse events were recorded and managed daily. The program was implemented prior to the onset of peak adult mosquito activity and field teams remained in situ continuing the Active Case Detection until the end of the mosquito season.

An immigrant population of 1270 persons was identified, mostly from Pakistan and Afghanistan. MDA covered 87% of this population. Of the treated individuals 13% reported gastrointestinal symptoms from primaquine, while 36% reported non-severe side effects from chloroquine including headaches, dizziness and gastrointestinal complaints. One potentially serious adverse event was recorded; a case of primaquine-induced hemolysis due to a false normal G6PD level obtained prior to enrollment. The patient was hospitalized and recovered fully.

In this case, mass drug administration was a suitable and effective response for a small and geographically confined population over a short seasonal transition period. The combination of two drugs minimizes the risk of drug resistance. Although an observational study of this nature cannot assess the extent to which mass drug administration was responsible for eliminating malaria, it certainly indicates that mass drug administration should be considered and can be effective in local settings alongside other malaria control measures.


Please contact if you would like more information about our content and specific topics of interest.

All works published in PLOS Neglected Tropical Diseases are open access, which means that everything is immediately and freely available. Use this URL in your coverage to provide readers access to the paper upon publication: (Link goes live upon article publication)

Press-Only Preview Of The Article:

Contact: Christos Hadjichristodoulou, 0030 2410 565050,

Funding: The data collected in the context of "Integrated Surveillance and control programme for West Nile Virus and malaria in Greece MIS 365280 (MALWEST Project )" which is implemented through the Operational Programme entitled "Human Resources Development" of National Strategic Reference Framework" (NSRF) 2007-2013. The programme is co-funded by Greece and the European Union--European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

About PLOS Neglected Tropical Diseases

PLOS Neglected Tropical Diseases is a peer-reviewed, open-access journal devoted to the pathology, epidemiology, prevention, treatment, and control of the neglected tropical diseases, as well as public policy relevant to this group of diseases. All works published in PLOS Neglected Tropical Diseases are open access, which means that everything is immediately and freely available subject only to the condition that the original authorship and source are properly attributed. The Public Library of Science uses the Creative Commons Attribution License, and copyright is retained by the authors.

About the Public Library of Science

The Public Library of Science (PLOS) is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource. For more information, visit

Media Permissions

PLOS Journals publish under a Creative Commons Attribution License, which permits free reuse of all materials published with the article, so long as the work is cited (e.g., Kaltenbach LS et al. (2007) Huntington Interacting Proteins Are Genetic Modifiers of Neurodegeneration. PLOS Genet 3(5): e82. doi:10.1371/journal.pgen.0030082). No prior permission is required from the authors or publisher. For queries about the license, please contact the relative journal contact indicated here:

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.